Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Filings indexed 970 across all filing types
Latest filing 2023-05-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于取得医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (771 characters) about obtaining a medical device registration change document issued by a national regulatory authority (国家药品监督管理局). It details a change in product technical requirements for a specific medical device and states that the change will not have a significant impact on the company's operations. There is no financial data, no mention of financial results, no detailed report content, and no indication of a meeting or voting results. The document is clearly an official regulatory announcement about a product registration change, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it contains substantive information about the registration change itself. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-05-04 Chinese
第三届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is titled '监事会决议公告' which translates to 'Supervisory Board Resolution Announcement'. It details the meeting of the supervisory board held on April 24, 2023, where the board reviewed and approved the company's 2023 first quarter report. The document states that the supervisory board agrees that the report complies with laws and regulations and reflects the company's actual situation accurately. However, the document itself does not contain the full quarterly report but rather a resolution approving it and refers readers to the official disclosure website for the full report. The document length is short (913 characters) and it is an announcement of the supervisory board's resolution rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the supervisory board's approval of the quarterly report, not the quarterly report itself.
2023-04-24 Chinese
关于2023年第一季度报告披露的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (454 characters) indicating that the company's 2023 first quarter report has been approved and will be disclosed on a regulatory website. It does not contain the actual financial data or detailed report content but serves as a notice to investors to check the full report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2023-04-24 Chinese
第三届董事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board resolution announcement from the company Yantai Zhenghai Biotechnology Co., Ltd. It reports the approval of the company's 2023 first quarter report by the board of directors. The document is short (810 characters) and explicitly states that the detailed quarterly report is disclosed on the official regulatory website. This indicates that the document itself is not the quarterly report but an announcement of the board's resolution regarding the report. According to the 'Menu vs Meal' rule, such a document is classified as a Regulatory Filing (RNS) because it announces the approval and references the actual report elsewhere, without containing substantive financial data itself.
2023-04-24 Chinese
2023年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2023 年第一季度报告' which translates to '2023 First Quarter Report' and contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2023. It explicitly states it is a quarterly report and is unaudited. The content includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. There is no indication that this is an announcement of a report or a certification document. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-24 Chinese
关于完成工商变更登记的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of industrial and commercial registration changes, specifically the change of the company's legal representative due to a board decision to elect a new chairman. It details the change in the company's legal representative and the completion of the related registration procedures with the market supervision bureau. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond this corporate governance update. This fits the category of Board/Management Information (MANG), as it announces a change in senior management (the chairman and legal representative). The document length is short and it is a direct announcement, not a report or certification.
2023-04-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.